We are aware of current issues with the ONS login. Please clear your device history/cache/cookies before attempting to log in. Thank you for your patience as we address this issue.
cancel
Diagnose and Manage Dermatologic Toxicity Secondary to Immunotherapy
Wendy Vogel MSN, FNP, AOCNP®
Voice
Description
Dermatologic toxicity is the most common side effect secondary to immunotherapy. The majority of dermatologic adverse events are mild to moderate rashes on the truck of the body and upper extremities, pruritis, and vitiligo.